Biotechnology
/
Northern Norway

Biotec Pharmacon Asa
Biotechnology company

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenue: 15.075
    Operating profit: -9.104
    Operating profit before tax: -8.253
    Total assets: 301.262
    Total equity: 297.076
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Marie Ann Roskrow


    Board Members:
    Arne Reinemo
    Inger Christina Rydin
    Martin Braddock Hunt






    General Manager:
    Christian Jørgensen


    Subsidiary companies:
    Largest shareholders:
    N/A
  • Trademarks
    MacroGard,
MacroGard,
    Basic organic chemicals, Biotechnology, Diagnostic agents, Enzymes, Research services, Terapeutica,